Propanc, The Australian Biotech, Turns To Crypto To Tackle Cancer
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure Propanc Biopharma said it has struck a deal to raise up to $100 million to build a digital asset treasury that will support its cancer-treatment program. Based on reports, the arrangement with Hexstone Capital begins with an initial injection of $1 million…
